Reimbursed with a limitationOriginator productATC L01EA03

Tasigna

Tasigna is an originator product from Novartis Pharma Schweiz AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 926.60 to CHF 3'001.85 depending on the pack; the patient co-payment is 40 per cent plus the deductible.

Core data

Authorisation holder
Novartis Pharma Schweiz AG
ATC code
L01EA03
IT group
07.16.10 Cytostatica
Active substances
Nilotinibum
Preparation type
Originator product
On the SL since
01/08/2007
Last price change
01/03/2024
Co-payment
40%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Tasigna Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Kaps 150 mg112 StkCHF 1'876.76CHF 1'999.7501/10/2010A7680580070049
Kaps 200 mg28 StkCHF 861.28CHF 926.6001/08/2007A7680580070018
Kaps 200 mg112 StkCHF 2'825.01CHF 3'001.8501/08/2007A7680580070025

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/10/2010

Erstlinienbehandlung von erwachsenen Patienten mit Philadelphiachromosom-positiver chronischer myeloischer Leukämie (Ph+ CML) in der chronischen Phase.

FOPH wordingValid from 01/01/2007

Behandlung von Patienten mit Philadelphiachromosom positiver chronischer myelioscher Leukämie (Ph+ CML) in der chronischen und in der akzelerierten Phase bei Resistenz oder hoher Toxizität unter Vorbehandlung mit Imatinib.

More preparations in this group

FAQ

Is Tasigna covered by Swiss health insurance?

Yes, but only under conditions. Tasigna is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Tasigna cost in Switzerland?

The public price is the maximum price set by the FOPH and for Tasigna ranges from CHF 926.60 to CHF 3'001.85 per pack. The ex-factory price ranges from CHF 861.28 to CHF 2'825.01. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com